Stockscreener 앱 받기
0.1006
0.40%
0.0004
Applied Therapeutics Inc 주식(APLT)의 최신 뉴스
Support Test: Why Applied Therapeutics Inc. stock attracts global investorsTrend Reversal & Low Drawdown Momentum Ideas - ulpravda.ru
Leerink Partners downgrades Applied Therapeutics (APLT) - MSN
Why Applied Therapeutics Inc. stock attracts global investorsWeekly Loss Report & AI Forecast Swing Trade Picks - ulpravda.ru
Bond Watch: Will Applied Therapeutics Inc. stock continue dividend increasesDip Buying & Daily Technical Forecast Reports - ulpravda.ru
Can Applied Therapeutics Inc. stock beat analyst upgradesJuly 2025 Selloffs & AI Enhanced Trading Signals - ulpravda.ru
Will Applied Therapeutics Inc. stock continue dividend increasesWeekly Market Report & Free Technical Pattern Based Buy Signals - ulpravda.ru
Aug Analyst Calls: Will Applied Therapeutics Inc. stock see insider buyingJuly 2025 Fed Impact & Low Risk Entry Point Guides - ulpravda.ru
Will Applied Therapeutics Inc. stock see insider buyingQuarterly Trade Review & Free Risk Controlled Daily Trade Plans - ulpravda.ru
Why Applied Therapeutics Inc. (2UV) stock is upgraded to buyTrade Analysis Report & Weekly Watchlist of Top Performers - ulpravda.ru
Published on: 2026-01-07 21:50:31 - ulpravda.ru
RSI Check: Why Applied Therapeutics Inc stock attracts global investorsJuly 2025 Technicals & Growth-Oriented Investment Plans - moha.gov.vn
Applied Therapeutics (APLT) Upgraded to Buy: Here's Why - MSN
Applied Therapeutics To Lay Off Nearly Half Its Staff, Board Explores M&A Options - MSN
EBITDA per share of Applied Therapeutics, Inc. – FWB:2UV - TradingView — Track All Markets
Applied Therapeutics $15M Securities Class Action Settlement - Claim Depot
APLT DEADLINE NOTICE: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important February 18 Deadline in Securities Class ActionAPLT - Macau Business
Applied Therapeutics (APLT) price target decreased by 85.00% to 0.26 - MSN
Why Applied Therapeutics Inc. stock remains a top recommendationMarket Sentiment Summary & Fast Moving Trade Plans - bolumsonucanavari.com
What analyst consensus says on Applied Therapeutics Inc. stockStop Loss & Risk Managed Investment Strategies - Улправда
Is Applied Therapeutics Inc. (2UV) stock cheap vs fundamentalsWeekly Stock Summary & Real-Time Market Sentiment Reports - Улправда
Will Applied Therapeutics Inc. stock maintain momentum in 2025 - Bölüm Sonu Canavarı
Is Applied Therapeutics Inc. stock a safe buy before earningsQuarterly Market Review & Fast Gaining Stock Strategy Reports - Улправда
How Applied Therapeutics Inc. (2UV) stock stacks up against competitorsMarket Performance Report & Safe Swing Trade Setup Alerts - DonanımHaber
Why Applied Therapeutics Inc. stock is recommended by analysts2025 Fundamental Recap & Long-Term Investment Growth Plans - Улправда
Applied Therapeutics, Inc.(NasdaqCM: APLT) dropped from NASDAQ Biotechnology Index - marketscreener.com
Published on: 2025-12-19 02:08:41 - Улправда
Dir Kanter Sells 43,000 ($4.8K) Of Applied Therapeutics Inc [APLT] - TradingView — Track All Markets
Applied Therapeutics (APLT) director reports sale of 43,000 shares on Form 4 - Stock Titan
Published on: 2025-12-18 17:03:31 - Улправда
Applied Therapeutics Earnings Notes - Trefis
United StatesGoodwin Represents Cycle Pharmaceuticals In Acquisition Of Applied Therapeutics - Mondaq
Here's Why Applied Therapeutics (APLT) Is a Great 'Buy the Bottom' Stock Now - Finviz
Halper Sadeh LLC Encourages QIPT, FITB, GBIO, APLT Shareholders to Contact the Firm to Discuss Their Rights - Sahm
Dir Kanter Files To Sell 43,000 Of Applied Therapeutics Inc [APLT] - TradingView — Track All Markets
British drugs company Cycle Pharma snaps up US competitor - The Times
Applied Therapeutics announces merger with Cycle Group - MSN
Halper Sadeh LLC Encourages ALEX, DXLG, APLT Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewswire Inc.
Applied Therapeutics to be acquired by Cycle Pharmaceuticals - MSN
RBC Capital Sticks to Its Hold Rating for Applied Therapeutics (APLT) - The Globe and Mail
SHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating the Merger-ALEX, DVS, DXLG, and APLT - The Malaysian Reserve
Applied Therapeutics stock rating downgraded to Neutral by Baird - Investing.com Canada
Cycle buying Applied Therapeutics to develop CNS drugs - BioWorld MedTech
S&P 500 Down 1%; Broadcom Earnings Top Views - Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Cycle Pharma to acquire Applied Therapeutics - The Pharma Letter
Cycle Group Holdings Limited entered into a definitive agreement to acquire Applied Therapeutics, Inc. for $13.4 million. - marketscreener.com
Dow Rises Over 100 Points; Lululemon Posts Upbeat Q3 Earnings - Benzinga
Applied Therapeutics (APLT) Stock News Today: Cycle Deal Details, CVR Upside, and Analyst Outlook (Dec. 12, 2025) - ts2.tech
RBC Cuts Price Target on Applied Therapeutics to $0.25 From $1, Keeps Sector Perform, Speculative Risk - marketscreener.com
APLT Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Applied Therapeutics, Inc. is Fair to Shareholders - The AI Journal
Applied Therapeutics Announces Merger with Cycle Group - TipRanks
Applied Therapeutics plunges after UK's Cycle Group to buy co - TradingView — Track All Markets
Applied Therapeutics stock price target lowered by RBC on Cycle acquisition - Investing.com Canada
Why Lululemon Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket - Benzinga
0.90%
자본화:
|
볼륨(24시간):